Manufacturing issues lead to shortage of popular impetigo remedy
The TGA is advising health professionals and consumers that there is a shortage of Bactroban (mupirocin) 20 mg/g ointment tubes.
Bactroban 20 mg/g ointment is used for the topical treatment of mild impetigo.
The product’s sponsor, GlaxoSmithKline Australia, has advised the TGA that the shortage is related to manufacturing issues and product is expected to be available again after 31 October 2016.
An alternative supply has been arranged with the TGA approval of a section 19A for the import and supply of a UK product, Mupirocin 20 mg/g ointment tube.
Pharmacies can obtain Mupirocin 20 mg/g ointment tubes by contacting Medsurge by phone (1300 788 261) or email
For more information, click here.